Pilot Study of Fecal Mitochondrial DNA in Inflammatory Bowel Disease Patients Demonstrates a High Sensitivity Assay With Likely Capacity to Differentiate Between Disease and Histologic Remission
Saved in:
| Main Authors: | Kevin Zhu, Thomas Wallach, Shagun Sharma, Vivian Vega, Meredith Pittman, Joe Brown |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Gastro Hep Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572325000093 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis
by: Arshdeep Singh, et al.
Published: (2025-04-01) -
Beyond mucosal healing: fecal calprotectin and the path toward histologic remission in ulcerative colitis
by: Yehyun Park
Published: (2025-04-01) -
Rediscovering histology – the application of artificial intelligence in inflammatory bowel disease histologic assessment
by: Giovanni Santacroce, et al.
Published: (2025-03-01) -
Fecal Mycobiota in Patients with Inflammatory Bowel Diseases and Extraintestinal Manifestations
by: Sandra Hertz, et al.
Published: (2024-12-01) -
Fecal Transplant Sustained Colitis Remission on Immunotherapy Resumption
by: Rajan Amin, et al.
Published: (2022-12-01)